Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Michael Haller MD

Michael J. Haller MD

Professor and Chief, Pediatric Endocrinology, Department of Pediatrics, University of Florida Diabetes Institute, Gainesville, Florida

Dr. Michael Haller is a pediatric endocrinologist with a passion for patient care, teaching, and research. He is a Gainesville native and a proud graduate of the University of Florida’s College of Medicine, Pediatrics Residency, and Pediatric Endocrinology Fellowship Programs.

In addition to serving as the Pediatric Endocrinology Chief and Fellowship director, Dr. Haller coordinates an active research team focused on the prediction, prevention, and reversal of type 1 diabetes.

Recent Contributions to PracticeUpdate:

  1. C-Peptide and Metabolic Outcomes in Trials of Disease-Modifying Therapy in Patients With New-Onset Type 1 Diabetes
  2. Initiation of Pre-Symptomatic Islet Autoimmunity in Patients With Type 1 Diabetes
  3. Type 1 Diabetes Can Present Before the Age of 6 Months and Is Characterized by Autoimmunity and Rapid Loss of Beta Cells

Most Read This Week

Recently Updated